Nan Shao

58# Zhongshan Two Road
Guangzhou, 510080, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Soluble HER2 promotes chronic antigen-mediated CD8⁺ T-cell dysfunction and limits immunotherapy response in HER2-low triple-negative breast cancer.

Soluble HER2 promotes chronic antigen-mediated CD8⁺ T-cell dysfunction and limits immunotherapy response in HER2-low triple-negative breast cancer.

Journal: Cell death & disease

Published: March 22, 2026

Tumor-derived PCSK9-enriched exosomes reprogram adipocytes to drive metabolic dysregulation and immune evasion in triple-negative breast cancer.

Tumor-derived PCSK9-enriched exosomes reprogram adipocytes to drive metabolic dysregulation and immune evasion in triple-negative breast cancer.

Journal: Cell death & disease

Published: September 11, 2025

Prognosis and endocrine therapy efficacy in early breast cancer with estrogen receptor low expression.

Prognosis and endocrine therapy efficacy in early breast cancer with estrogen receptor low expression.

Journal: Breast cancer research and treatment

Published: September 08, 2025

Expression and clinical significance of CD155, FGL1, Galectin-9, and PD‑L1 in breast cancer with neoadjuvant chemotherapy.

Expression and clinical significance of CD155, FGL1, Galectin-9, and PD‑L1 in breast cancer with neoadjuvant chemotherapy.

Journal: Medical oncology (Northwood, London, England)

Published: March 18, 2025

Exploring the role of Mitoferrin-1 in Ferroptosis and mitochondrial damage in acute ischemic stroke.

Exploring the role of Mitoferrin-1 in Ferroptosis and mitochondrial damage in acute ischemic stroke.

Journal: International immunopharmacology

Published: February 11, 2025

Suppressing protein damage response to overcome multidrug resistance in cancer therapy.

Suppressing protein damage response to overcome multidrug resistance in cancer therapy.

Journal: Cell discovery

Published: February 04, 2025

Integrated immune-related gene signature predicts clinical outcome for patients with Luminal B breast cancer.

Integrated immune-related gene signature predicts clinical outcome for patients with Luminal B breast cancer.

Journal: Gland surgery

Published: August 27, 2024

Evaluating dynamic contrast-enhanced MRI for differentiating HER2-zero, HER2-low, and HER2-positive breast cancers in patients undergoing neoadjuvant chemotherapy.

Evaluating dynamic contrast-enhanced MRI for differentiating HER2-zero, HER2-low, and HER2-positive breast cancers in patients undergoing neoadjuvant chemotherapy.

Journal: European journal of medical research

Published: July 22, 2024

Intra- and peri-tumoral radiomics based on dynamic contrast-enhanced MRI for prediction of benign disease in BI-RADS 4 breast lesions: a multicentre study.

Intra- and peri-tumoral radiomics based on dynamic contrast-enhanced MRI for prediction of benign disease in BI-RADS 4 breast lesions: a multicentre study.

Journal: Radiation oncology (London, England)

Published: July 14, 2024

Patterns of Recurrence and Survival Outcomes of HER2-Low Expression in Early-Stage Breast Cancer.

Patterns of Recurrence and Survival Outcomes of HER2-Low Expression in Early-Stage Breast Cancer.

Journal: Clinical breast cancer

Published: April 25, 2024

Genomic and transcriptomic profiling of inflammatory breast cancer reveals distinct molecular characteristics to non-inflammatory breast cancers.

Genomic and transcriptomic profiling of inflammatory breast cancer reveals distinct molecular characteristics to non-inflammatory breast cancers.

Journal: Breast cancer research and treatment

Published: February 23, 2024

A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast Cancer.

A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast Cancer.

Journal: Cancer research

Published: August 31, 2023

Showing 1-12 of 60

Last Updated: 09/26/2026